a r t I C l e S Despite the established role of multiple proteins in the pathogenesis of neurodegenerative disease, we know remarkably little about their function. In Parkinson's disease, as well as in the related conditions dementia with Lewy bodies and multiple system atrophy, the peripheral membrane protein α-synuclein accumulates in characteristic inclusions 1 . Mutations in α-synuclein also produce a dominantly inherited form of Parkinson's disease [2] [3] [4] [5] [6] [7] , demonstrating that the protein has a causative role. Indeed, α-synuclein gene duplication and particularly triplication produce a severe form of familial Parkinson's disease 8 , implicating the wild-type (WT) protein in disease. Synuclein thus has a central role in Parkinson's disease. However, the normal function of α-synuclein remains poorly understood.
α-Synuclein normally localizes to the nerve terminal, suggesting a role in neurotransmitter release 9 . Consistent with this, modest overexpression (insufficient to produce inclusions or overt toxicity) inhibits the regulated exocytosis of large dense core vesicles (LDCVs) and synaptic vesicles [10] [11] [12] . However, the loss of synuclein has less effect, with minimal or no increase in glutamate release reported in triple knockout (TKO) mice lacking α-synuclein as well as the closely related βand γisoforms 13, 14 . Knockout mice lacking αand γ-synuclein show an increase in evoked dopamine release 15 , but the physiological change responsible remains unknown. Although overexpression inhibits regulated exocytosis, the role of endogenous α-synuclein has thus remained unknown.
α-Synuclein binds specifically to anionic membranes with high curvature [16] [17] [18] but can also deform the lipid bilayer. Synuclein aggregates membranes in yeast 19, 20 , tubulates artificial membranes in vitro 21 and, when overexpressed in mammalian cells, can produce mitochondrial fragmentation 22, 23 . However, membrane deformation is generally considered to be more important to endocytosis than to exocytosis. The effect of overexpressed synuclein on exocytosis has thus been difficult to explain on the basis of membrane curvaturesensing or curvature-promoting properties. Alternatively, synuclein has been suggested to serve as chaperone for the SNARE complex, but without apparent effect on transmitter release 14 .
How might membrane deformation by synuclein influence regulated exocytosis? In the course of exocytosis, synaptic vesicles form a fusion pore that dilates before full collapse into the plasma membrane. However, the pore can also reclose during a kiss-and-run event that immediately regenerates the vesicle 24 . Regulation of membrane curvature might thus affect behavior of the fusion pore. Since classical transmitters such as glutamate escape rapidly, postsynaptic recording might not detect a change in fusion pore kinetics. We have therefore used imaging to monitor directly individual exocytotic events. Single synaptic vesicle fusion events are difficult to detect by imaging, so we have focused on peptidergic LDCVs due to their size (70-200 nm diameter) and relatively slow release. Adrenal chromaffin cells have been used extensively to study the process of regulated exocytosis, including release by kiss-and-run 25 , and previous work has indeed demonstrated the inhibition of LDCV exocytosis by synuclein overexpression in chromaffin cells 10 . α-Synuclein-positive Lewy pathology also occurs at high frequency in the adrenal glands of patients with Parkinson's disease and dementia with Lewy bodies 26 , with effects on catecholamine release into the circulation 27 .
RESULTS

Synuclein overexpression accelerates the kinetics of individual exocytotic events in chromaffin cells
To understand how synuclein influences release, we first infected primary cultures from the postnatal mouse adrenal medulla with a lentivirus encoding human α-synuclein. Double staining for human α-synuclein and the LDCV protein secretogranin II (SgII) confirmed a r t I C l e S expression of the human protein in chromaffin cells ( Supplementary  Fig. 1a ). We also assessed the expression of endogenous α-synuclein using an antibody that recognizes the protein from multiple species. Comparison of chromaffin cells from WT and synuclein TKO mice lacking all synuclein isoforms showed that chromaffin cells express endogenous α-synuclein and the lentivirus confers modest overexpression ( Supplementary Fig. 1b,c) .
To study individual exocytotic events, we used a fusion of brainderived neurotrophic factor (BDNF) to the ecliptic pHluorin, a modified form of green fluorescent protein with enhanced pH sensitivity 28 . Quenched at the low pH of LDCVs, BDNF-pHluorin fluorescence increases on exposure to the external medium by exocytosis 29 . We monitored the behavior of BDNF-pHluorin by total internal reflection fluorescence (TIRF) microscopy during depolarization with 45 mM K + . Since kiss-and-run may occur more frequently at high external Ca 2+ (ref. 30) , we also used 5 mM external Ca 2+ to sample a wider variety of exocytotic events. α-Synuclein overexpression reduces the number of exocytotic events detected using BDNF-pHluorin ( Fig. 1a) , as suggested previously by amperometry 10 . A change in Ca 2+ entry cannot account for this reduction because Ca 2+ entry does not significantly differ among WT, synuclein-overexpressing and TKO cells ( Supplementary Fig. 2) .
Individual exocytotic events showed a series of characteristic changes due to the overexpression of α-synuclein. First, synuclein overexpression increased the rate of fluorescence rise. Although BDNF-pHluorin unquenching occurs rapidly at exocytosis, the fluorescence of many events increases over more than a single frame 31 , and this reflects buffering as well as dissolution of the LDCV core 32 . Alkalization or approach to the plasma membrane might produce similar behavior, but loss of a preloaded dye 33 accompanies or precedes events with slow rise times ( Supplementary Fig. 3a,b) . Thus, synuclein overexpression increased the rate of H + loss at exocytosis ( Fig. 1b and Supplementary Fig. 4a-c) . Second, after peak fluorescence, the rate of fluorescence decay (due to peptide release) also increased even when analyzed as means per cell rather than aggregated, individual exocytotic events ( Supplementary Fig. 4d ). These results suggest acceleration of the release event by α-synuclein. In full decay, the fluorescence immediately decays to baseline. In plateau-decay, the fluorescence decay begins after a variable latency. In decay-closure, the fluorescence decays with no latency but the decay arrests before return to baseline. Plateau-decay-closure involves both a latency before decay and incomplete decay. The diagrams (upper right) illustrate our interpretation of the traces. The proportion of event types differed among all three groups (P < 0.0001 by chi-squared test for pairwise as well as the comparison of all three groups). (d) Synuclein influences the rate of BDNF release. For all full decay events, the time constant of fluorescence decay (τ decay ) was determined by fitting to a single exponential. The histogram represents the distribution of events with different τ decay (P < 0.0001 for WT versus SYN and TKO versus SYN; P < 0.001 for WT versus TKO by Kolmogorov-Smirnov test). WT, n = 266 events; SYN, n = 167 events; TKO, n = 237 events.
(e) For all events with nonzero latency to decay, the time from reaching 90% maximal fluorescence to the onset of decay was determined (WT, n = 134 events; SYN, n = 66 events; TKO, n = 218 events). Boxes represent the middle two quartiles, whiskers 10% and 90% of the events, the line the median and the + the mean. ****P < 0.0001 by Kruskal-Wallis one-way ANOVA with Dunn's post hoc test; H = 55.22 (d) and 39.45 (e).
a r t I C l e S However, the fluorescence events fall into at least four distinct classes ( Fig. 1c and Supplementary Fig. 4e ). Many events decayed immediately to baseline (full decay) whereas others remained at maximum fluorescence for an interval before full decay (plateau-decay). In still others, decay was interrupted, suggesting constriction if not closure of the fusion pore, with or without a plateau preceding the decay (decay-plateau or plateau-decay-plateau). To determine whether the interruption of fluorescence decay reflects full pore closure, we quenched residual events using external solution adjusted to pH 5.5 with the impermeant buffer MES (Supplementary Fig. 3c ). All events in the process of decay showed quenching by the acidic buffer ( Supplementary Fig. 3d ), demonstrating exocytosis and either full collapse or persistence of a dilated fusion pore rather than movement away from the plasma membrane. Indeed, the H + -ATPase inhibitor bafilomycin did not influence the time course of events in any genotype ( Supplementary Fig. 3e ), confirming that loss of fluorescence indicates the release of peptide, not reacidification. Most of the stable events (plateaus) also showed quenching by low external pH, but a fraction did not ( Supplementary Fig. 3c,d) . Thus, complete closure of the fusion pore occurs only in stable events, but incomplete closure can still limit the loss of peptide. Consistent with the acceleration of release, synuclein overexpression increased the proportion of events that undergo full decay ( Fig. 1c) . Within the group undergoing full decay, however, synuclein overexpression also increased the rate of decay ( Fig. 1d and Supplementary Fig. 4f ). Thus, synuclein accelerates release independent of effects on pore closure, suggesting a role early in exocytosis in promoting peptide release. Overexpression of synuclein also had no effect on the number of docked vesicles or their luminal pH ( Supplementary Fig. 5 ), arguing against a general disturbance of LDCVs as cause for the change in exocytosis.
Loss of synuclein prolongs the kinetics of release
The difficulty detecting clear effects on transmitter release in knockout mice 11, 13, 14 suggests that α-synuclein overexpression may simply produce toxicity that secondarily affects release. It was therefore of great interest to determine how the loss of synuclein influences release kinetics. Consistent with previous work in neurons 11, 13, 14 , chromaffin cells from synuclein TKO mice showed no clear change in event number relative to WT ( Fig. 1a) . However, analysis of event distribution revealed an increase in the time to peak fluorescence ( Fig. 1b and Supplementary Fig. 4a,b) . Loss of the synucleins modestly reduced the proportion of events with full decay ( Fig. 1c) and also redistributed the decay time constants to longer values ( Fig. 1d ). In addition, TKO cells showed greatly increased latency to decay among those events that did not decay immediately ( Fig. 1e) . (Overexpression did not affect this parameter presumably because it converts those with a short latency to full decay.) Thus, loss of synuclein prolongs release, suggesting a similar role for the endogenous and overexpressed protein in exocytosis. Like overexpression, the synuclein TKO also had no effect on LDCV docking or pH ( Supplementary Fig. 5 ).
Although we used 5 mM external Ca 2+ for these experiments because it may promote kiss-and-run, we also examined BDNF-pHluorin events at the more physiological 2 mM Ca 2+ . In this condition, as in 5 mM Ca 2+ , overexpression of human α-synuclein both inhibited the exocytosis of chromaffin granules and accelerated the loss of BDNF-pHluorin ( Supplementary Fig. 6a,b) . The proportion of events again shifted to those with full decay at the expense of those with interrupted release, and the time constant for fluorescence decay shortened ( Supplementary Fig. 6c,d) . The TKO also showed prolonged decay relative to WT (Supplementary Fig. 6d ). Thus, synuclein has similar effects on release at 2 and 5 mM Ca 2+ .
Synuclein inhibits closure of the fusion pore (kiss-and-run)
The effect of synuclein on release could reflect changes in the fusion pore or in the solubility of dense core vesicle cargo. Indeed, the same LDCVs can release different substances at different rates 34, 35 , indicating a r t I C l e S that the properties of the aggregated peptide can influence the rate of release. It seems unlikely that a cytoplasmic protein such as synuclein would influence luminal contents, but to distinguish further between effects on the fusion pore and on peptide solubility, we used a construct with the pHluorin inserted into a luminal loop of the vesicular monoamine transporter VMAT2 (ref. 36 ), a polytopic membrane protein that localizes to LDCVs. Stimulation of endocrine cells expressing the fusion produced discrete exocytotic events consistent with LDCVs, and we used bafilomycin for these experiments to prevent vesicle reacidification. In chromaffin cells, α-synuclein overexpression also inhibited the exocytosis of VMAT2-pHluorin ( Fig. 2b) .
As a membrane protein, VMAT2-pHluorin cannot undergo release, and its decay therefore reflects spread within the plasma membrane and endocytosis, processes limited by the fusion pore 37 . Indeed, we observed events that spread and others that did not, as well as variation in the time course of fluorescence decay ( Fig. 2a) . Although the proportion of events with a latency to decay did not differ (46% for synuclein overexpression, 44% for control), the latency to decay shortened with overexpression of α-synuclein (Fig. 2b,c) . The long duration of VMAT2-pHluorin events also enabled us to determine how many remain accessible to the external solution. We found that a substantial fraction of the persistent events in control chromaffin cells were protected from quenching by MES-buffered solution at pH 5.5 (Fig. 2d,e ), indicating kiss-and-run. In cells overexpressing human α-synuclein, this fraction declined substantially ( Fig. 2e ),
suggesting inhibition of pore closure. However, synuclein overexpression also shortened the time constant of fluorescence decay for VMAT2-pHluorin ( Fig. 2f) , again supporting an independent effect on the rate of release, and a skew in the distribution of events per cell does not account for the effect on latency to decay or rate of decay ( Supplementary Fig. 7) . The analysis of membrane protein exocytosis thus supports an effect of synuclein on peptide release that cannot be explained by changes in cargo solubility.
Endogenous and overexpressed synuclein promote fusion pore dilation in neurons Does synuclein also affect the properties of individual exocytotic events in neurons? To address this, we first expressed human α-synuclein in primary rat hippocampal neurons, imaging cotransfected BDNF-pHluorin ( Fig. 3) . Quantitative western analysis using an antibody that recognizes both human and rodent α-synuclein showed 4-to 5-fold overexpression (Supplementary Fig. 8) . As previously reported 38, 39 , stimulation at 50 Hz evoked discrete exocytotic events primarily in axons (Fig. 3a) . The average number of events per coverslip did not significantly change with synuclein overexpression ( Fig. 3c) , but quenching at low pH revealed a dramatic effect of synuclein on the proportion of events accessible to external solution (P < 0.0001 by chi-squared test) ( Fig. 3d) . With overexpression, more events decayed before the addition of low-pH solution (Fig. 3a,d) , indicating that, as in chromaffin cells overexpressing synuclein, the Middle trace shows an event that did not decay completely but showed oscillation throughout, indicating that the fusion pore did not close. Bottom trace shows an event where the oscillation stopped (arrow) before full peptide release, indicating pore closure. (f) The proportion of event types differs in WT and synuclein TKO neurons (P = 0.01 by chi-squared test). n = 100 events from 7 (WT) and 9 (TKO) coverslips. (g) Among events with pore closure, the cumulative frequency distribution shows no significant difference between WT and synuclein TKO neurons in time to pore closure (P = 0.63 by Kolmogorov-Smirnov test). Inset plots time to pore closure, with boxes representing the middle two quartiles, whiskers 10% and 90% of the events, the line the median and the + the mean (n.s., not significant). n = 44 events for WT and 63 events for TKO. a r t I C l e S events decay more rapidly. Even among those events that remained, however, synuclein overexpression increased the proportion externally quenchable by low pH (Fig. 3b,d) , demonstrating that α-synuclein has an effect on the fusion pore independent of release rate. Neurons express high levels of multiple synuclein isoforms, suggesting that the effect of the TKO might be greater than in chromaffin cells, which express modest levels. We were thus surprised that the synuclein TKO had little effect on the proportion of events already decayed, unquenchable or quenchable by low pH (Supplementary  Fig. 9 ). However, BDNF-pHluorin events in neurons persisted for many seconds (Fig. 3b) , making it difficult to detect any further prolongation due to the loss of synuclein, and the acid quench limits characterization of the fusion pore to a single time point. We therefore turned to the reporter NPY-pHluorin due to its more rapid release from LDCVs 34, 39 . To determine how much of the decay in fluorescence reflects peptide release or reacidification, we again used the H + -ATPase inhibitor bafilomycin. A small subset of NPY-pHluorin events decayed slowly, with a time constant more than 5 s, and their proportion was reduced by bafilomycin ( Supplementary Fig. 10a) . At the same time, bafilomycin increased the proportion of events with no decay by a similar amount. Thus, a small fraction of events exhibit pore closure and reacidify slowly after endocytosis. However, the vast majority of events were rapid, with a time constant of decay considerably less than 5 s, and bafilomycin did not significantly change their proportion (Supplementary Fig. 10a ). Bafilomycin also did not alter the decay kinetics of most events (Supplementary Fig. 10b) . Thus, fast NPY-pHluorin events reflect peptide release and only the longest events undergo pore closure.
Much as in chromaffin cells, overexpression of α-synuclein in neurons shortened both the latency of NPY-pHluorin events to decay and a r t I C l e S the time constant for fluorescence decay once this began (Fig. 4a-c) .
Conversely, the loss of all three synucleins dramatically increased the latency of NPY-pHluorin to decay and the time constant of fluorescence decay (Fig. 4d,e ). The TKO thus has a more pronounced effect on the kinetics of LDCV exocytosis in neurons than in chromaffin cells, presumably because neurons express much higher levels of endogenous synuclein, and the difference cannot be attributed to a skewed distribution of events per cell (Supplementary Fig. 11 ). Of note, the effect of synuclein on NPY-pHluorin fluorescence decay appeared to involve only the more slowly decaying exocytotic events (Fig. 4c,e) , which the experiment with bafilomycin suggests undergo pore closure (Supplementary Fig. 10) . Presumably, it is difficult to detect acceleration of more rapidly decaying events because they are already very rapid. However, we also found that the latency from event appearance to the onset of decay shortened with overexpression of synuclein and lengthened in the TKO, but only for the events that decay rapidly (τ < 1 s), which are more common (Supplementary Fig. 12) .
In chromaffin cells and neurons, synuclein overexpression affected the accessibility to quenching by external H + , as well as the kinetics of peptide release, indicating changes in behavior of the fusion pore. To monitor fusion pore closure with higher temporal resolution, we oscillated the pH of neuronal cultures between 6.4 and 7.8. If the fusion pore is open, the changes in pH will affect fluorescence of the peptide-pHluorin. When the oscillation in fluorescence stops, this indicates pore closure. We used BDNF-pHluorin for this experiment because the events last longer and can thus provide information about pore closure relatively long after exocytosis begins. Figure 3e shows sample traces for events where the pore remained open until peptide release, where closure did not occur during the period imaged, and for a closure event. Inactivation of all three synuclein genes substantially increased the proportion of events with pore closure, at the expense of those without closure (P = 0.01 by chi-squared test) ( Fig. 3f) . However, loss of synuclein did not affect the time to pore closure (Fig. 3g) . Taken together with the NPY-pHluorin data, these results suggest that synuclein prevents interruption of release by pore closure in two ways: first, by increasing the rate of release and second, by preventing pore closure.
Synuclein localizes to dense core vesicles Does synuclein affect behavior of the fusion pore directly or indirectly? Despite its presynaptic location, its original identification in a preparation of synaptic vesicles and its preference for artificial membranes with high curvature 17 , α-synuclein exhibits only weak association with synaptic vesicles by gradient fractionation and photobleaching 40, 41 . We also failed to detect any specific localization of either overexpressed or endogenous synuclein with SgII in chromaffin cells using a number of commercially available antibodies. These antibodies produce diffuse labeling (Supplementary Fig. 1) . We were therefore surprised to find that an antibody to the homologous canary protein synelfin specifically labeled LDCVs in these cells. Using this antibody, which recognizes both αand β-synuclein 42 , overexpressed human α-synuclein colocalized extensively with the LDCV protein SgII by structured illumination microscopy (Fig. 5) . The same antibody detected endogenous synuclein on secretory granules in bovine chromaffin cells (M.A. Bittner and R.W. Holz, personal communication). Endogenous synuclein also colocalized with SgII, and the immunoreactivity for synuclein is specific because the TKO showed very low background staining ( Fig. 5 and Supplementary Fig. 13) . Supporting the specificity for LDCVs, endogenous synuclein showed little colocalization with mitochondria ( Fig. 5b and Supplementary   Fig. 14) . Further, the colocalization persisted on LDCVs away from as well as at the plasma membrane, indicating that synuclein associates with LDCVs before docking. Owing perhaps to conformational specificity for the membrane-bound or multimeric protein [43] [44] [45] , this antibody thus provides what may be the first direct histological evidence for the specific localization of synuclein to neurosecretory vesicles, indicating the potential for a direct effect on release.
Effect on pore dilation is conserved among isoforms but inhibited by mutations associated with Parkinson's disease The N terminus of α-synuclein contains seven 11-amino-acid repeats that form an amphipathic α-helix upon interaction with membranes containing acidic phospholipid headgroups 16 . In addition to membrane association, the repeats may contribute to function, such as on the fusion pore. Since the three synuclein isoforms a r t I C l e S show strong sequence conservation in the repeats and diverge at the more hydrophilic C terminus, we tested the role of the N terminus by examining the effects of βand γ-synuclein. Transduced into WT mouse chromaffin cells along with BDNF-pHluorin, human βand γ-synuclein both reduced the number of exocytotic events (Fig. 6a) , as in the effect of α-synuclein in chromaffin cells and the effect of multiple synuclein isoforms on synaptic vesicle exocytosis 11 . In the events that remained, βand γ-synuclein also accelerated peptide release (Fig. 6b) , again like α-synuclein. As the only conserved domain, the N-terminal repeats thus appear responsible for the effects on both event number and kinetics.
In previous work, we found that the mutations associated with Parkinson's disease do not impair the ability of α-synuclein to inhibit regulated exocytosis 10, 11 . The A30P mutant has less effect on synaptic vesicles because it does not concentrate at presynaptic boutons 46 , but the A53T mutant behaves very similarly to WT. In chromaffin cells, both of these mutants reduced the frequency of exocytotic events (Fig. 6a) , presumably because the small size of the cell eliminates the requirement for accumulation in a distant process 10 . Thus, we anticipated that the mutations would have similarly little effect on dilation of the fusion pore by synuclein. However, the mutations associated with Parkinson's disease all occur in a restricted region at the N terminus, at the end of the second repeat (A30P) and in the fourth (E46K, H50Q, G51D, A53T) 2-7 , suggesting interference with a specific function. Remarkably, we observed that A30P and A53T α-synuclein both failed to accelerate peptide release (Fig. 6b) . This is particularly surprising because the WT rodent α-synuclein gene contains the pathogenic threonine residue at this position. Other sequence differences between the species must therefore account for the pathogenicity of this residue. Independent of mechanism, the Parkinson's disease-associated mutations affected one function of synuclein (pore dilation) but not another (inhibition of exocytosis).
The preserved ability to inhibit exocytosis suggests that the Parkinson's disease-associated mutants localize normally to LDCVs. Indeed, immunofluorescence using the H3C antibody showed unimpaired colocalization of both mutants with SgII by TIRF microscopy (Fig. 6c ). Since this antibody does not distinguish between endogenous and introduced synuclein, we also examined the mutants in chromaffin cells from synuclein TKO mice and again observed no difference from endogenous synuclein in colocalization with SgII ( Fig. 6c and Supplementary Fig. 15 ).
DISCUSSION
The results show that synuclein influences behavior of the exocytotic fusion pore. Overexpression accelerates the release event, reducing the time to peak fluorescence (pore dilation), speeding fluorescence decay (peptide release) and preventing pore closure. The loss of synuclein produces opposite effects, increasing the time to peak fluorescence, The cumulative frequency distribution includes the decay constants for all BDNF-pHluorin events that decayed to baseline. Expression of either β-or γ-synuclein, but not mutant α-synuclein, shifted the decay constants to shorter values relative to control (P < 0.0001 by Kolmogorov-Smirnov test for con versus β-syn and con versus γ-syn). The inset plots the decay constants; boxes represent the middle two quartiles, whiskers 10% and 90% of the events, the line the median and the + the mean. ****P < 0.0001 by Kruskal-Wallis one-way ANOVA with Dunn's post hoc test (H = 76.76), con versus β-syn and con versus γ-syn; n = 610 events for control, 296 for A30P, 172 for A53T, 210 for β-synuclein and 265 for γ-synuclein. a r t I C l e S prolonging decay and increasing the likelihood of pore closure. Thus, both overexpressed and endogenous synuclein promote dilation of the fusion pore. Effects on pore closure are to some extent secondary to changes in the detection of undischarged cargo, but synuclein also appears to prevent closure during persistent events. Nonetheless, the effect on pore opening suggests that synuclein acts early in exocytosis. Changes in the fusion pore suggest an explanation for the inconsistent effects of synuclein on transmitter release reported in the literature. Fusion pore dilation would be expected to limit the release of neuromodulators such as monoamines and peptides that dissociate slowly from a luminal matrix, rather than classical transmitters such as glutamate that escape rapidly through even a small pore. Indeed, synuclein overexpression and loss both affect the release of dopamine 10, 15 . In contrast, loss of synuclein has little effect on glutamate release 13, 14 . Despite this apparent difference, we anticipate the same effects on fusion of any vesicle to which synuclein binds.
We also provide evidence for the specific association of endogenous as well as overexpressed synuclein with neurosecretory vesicles in cells, indicating the potential for direct effects on the fusion pore. Since synuclein associates with LDCVs before docking at the plasma membrane, it is possible that synuclein acts before fusion to influence its properties. Indeed, previous work showing that synuclein increases the number of SNARE complexes 14 suggests one mechanism for the effects of synuclein reported here. Increased SNARE complex formation might be expected to increase the force that drives fusion pore dilation and hence promote cargo release 47 . However, overexpression of synuclein also inhibits the extent of synaptic vesicle exocytosis 11 , and the results presented here confirm that this effect extends to LDCVs 10 . It is difficult to reconcile the observed inhibition of release with a role for synuclein as chaperone for the SNARE complex 14 . Indeed, synuclein inhibits the fusion of membranes in vitro as well as in vivo through direct effects on the lipid bilayer 22, [48] [49] [50] .
Alternatively, synuclein may promote SNARE complex accumulation by inhibiting exocytosis, thereby preventing the disassembly of complexes present on vesicles primed for fusion. In either case, synuclein appears to have a dual role. Physiologically, synuclein promotes dilation of the fusion pore, a dose-dependent effect shared by endogenous and overexpressed protein. By contrast, inhibition of exocytosis may be restricted to synuclein overexpression 13, 15 , suggesting a pathological role. Nonetheless, the inhibition of exocytosis appears dose-dependent 11 , much like the effect on fusion pore kinetics.
The effect of mutations associated with Parkinson's disease shows that the two activities of synuclein, to promote pore dilation and to inhibit exocytosis, are distinguishable. A30P and A53T mutations do not impair the inhibition of exocytosis by synuclein overexpression. However, they both eliminate the effect of synuclein on fusion pore dilation. Since the loss of synuclein affects fusion pore dilation but not the number of exocytotic events, the Parkinson's disease mutations appear to produce a selective loss in the normal function of the protein. The preserved ability of overexpressed mutant and WT synuclein to inhibit exocytosis may be required to produce degeneration.
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